FNCH
Finch Therapeutics Group Inc

742
Mkt Cap
$11.96M
Volume
1.00
52W High
$16.10
52W Low
$2.00
Price
$7.45
FNCH Fundamentals
Prev Close
$7.92
Open
$7.75
50D MA
$8.54
Beta
0.18
Avg. Volume
9,864.19
Loading...
Loading...

About

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Finch Therapeutics Group Inc?
What is the 52-week high for Finch Therapeutics Group Inc?
What is the 52-week low for Finch Therapeutics Group Inc?
What is Finch Therapeutics Group Inc stock price today?
What was Finch Therapeutics Group Inc stock price yesterday?
What is the 50-day moving average of Finch Therapeutics Group Inc?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available

Latest FNCH News

View
No FNCH news at the moment.
Top Discussions

Advertisement|Remove ads.